Page last updated: 2024-09-03

2-fluorodopa and Basal Ganglia Diseases

2-fluorodopa has been researched along with Basal Ganglia Diseases in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujiwara, T; Ido, T; Itoh, M; Itoyama, Y; Iwata, R; Kimura, I; Nagasawa, H; Nomura, H; Saito, H; Tanji, H; Tuji, S1

Other Studies

1 other study(ies) available for 2-fluorodopa and Basal Ganglia Diseases

ArticleYear
PET study of cerebral glucose metabolism and fluorodopa uptake in patients with corticobasal degeneration.
    Journal of the neurological sciences, 1996, Volume: 139, Issue:2

    Topics: Aged; Apraxias; Atrophy; Basal Ganglia; Basal Ganglia Diseases; Brain Diseases; Cerebral Cortex; Cerebrovascular Circulation; Deoxyglucose; Dihydroxyphenylalanine; Dominance, Cerebral; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Degeneration; Tomography, Emission-Computed

1996